Civio investigations
mental health
Since 2020 we have been focusing on mental healthcare, in particular on the real problems of access to the public system, the use of models that fail to respect rights, and the over-medicating of the population. Awards received for this investigation series:
- Runner-up in the Miradas Award 2022
- Europe’s Best Science Journalist Award 2022 for Ángela Bernardo, for her investigation into mental and reproductive health
- Observable Community Recognition Award 2021 for Carmen Torrecillas, for the visual and web development of this series
Antidepressant use in Europe continues to break records
Doctors continue prescribing anti-anxiety medications such as lorazepam or diazepam for long periods despite the risk of addictions. Meanwhile, under-investment in psychological care is making things worse.
The slow, uneven wane of the institutional psychiatry model in Europe
In the European Union, thousands of people with serious mental disorders live isolated and secluded from society, without receiving all the care they need. At least 150 million euros of European Union funds, intended to improve their situation, have been used for other purposes.
Pay up or put it off: how Europe treats depression and anxiety
In many European countries, the availability of psychological treatment in the public healthcare system is inadequate or even non-existent. Barriers such as long waiting lists, co-payments and inadequate resources push people with anxiety or depression -those who can afford it- to the private system.
If you want to know more about this topic, check out all our articles on Health